On Wednesday, Piper Sandler confirmed its Overweight rating on Align Technology (NASDAQ:ALGN) stock, with a steady price target of $275.00. According to InvestingPro data, analyst targets for the stock range from $206 to $320, with the company maintaining strong profitability metrics including a 70% gross margin and positive earnings of $5.86 per share over the last twelve months. The firm's analysis indicated a slight decrease in December clear aligner case volumes by 1.1% year-over-year. This contributed to a 4Q decline in U.S. orthodontic case volumes of 3.8%, according to their data. The full quarter results showed a downturn from the previous four quarters, which was anticipated following weaker performance in October and November.
Teen clear aligner volumes continued to lag, aligning with recent trends of underperformance in this demographic when compared to braces and wires. In light of these findings, Piper Sandler has adopted a more conservative stance on their 4Q and 2025 case volume projections for Align Technology. Despite the tempered expectations, Align Technology shares have seen a positive trajectory year-to-date, with an increase of 10%. InvestingPro analysis indicates the stock's notable volatility, with a beta of 1.67, while management has been actively buying back shares to support shareholder value.
The firm believes there is potential for near-term growth for Align Technology's stock, citing the current low valuation levels. However, they also noted that a stronger U.S. consumer environment might be a prerequisite for any significant increase in the company's stock multiple. Piper Sandler's commentary suggests a cautious yet optimistic outlook for Align Technology, as the market continues to navigate through the recent trends in the orthodontic industry. Based on InvestingPro's Fair Value analysis, the stock currently appears undervalued, with 6 additional ProTips and comprehensive financial metrics available to subscribers.
In other recent news, Align Technology has been the focus of several analyst ratings. Stifel maintained a Buy rating, emphasizing the company's potential for earnings per share growth by 2025 and a substantial cash position of $14 per share. Leerink Partners upgraded Align Technology from Market Perform to Outperform, citing improved company outlook and growth opportunities. Mizuho (NYSE:MFG) Securities initiated coverage with an Outperform rating, foreseeing significant upside potential.
The company has also announced its restructuring efforts, which analysts believe will help achieve its financial goals. Another key development is the receipt of the CE Mark in Europe for its Invisalign® Palatal Expander System, with plans for commercial availability across the EMEA region in Q1 2025.
These recent developments highlight Align Technology's strategic positioning and growth potential. The company's robust financial performance, strong partnerships, and innovative product portfolio are expected to drive its success in the coming years. The positive sentiments among analysts underscore the company's potential for a modest acceleration in year-over-year revenue growth by 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.